Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $6.9650 (-1.76%) ($6.9650 - $6.9650) on Wed. Aug. 30, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.12% (three month average) | RSI | 49 | Latest Price | $6.9650(-1.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.4% a day on average for past five trading days. | Weekly Trend | BCRX advances 0.9% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) SMH(73%) UNG(51%) XOP(32%) USO(29%) XLE(25%) | Factors Impacting BCRX price | BCRX will decline at least -1.56% in a week (0% probabilities). XLRE(-45%) ARKK(-43%) PCY(-39%) XLP(-36%) BLOK(-33%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.56% (StdDev 3.12%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
Resistance Level | $7.11 | 5 Day Moving Average | $7.15(-2.59%) | 10 Day Moving Average | $7.17(-2.86%) | 20 Day Moving Average | $7.11(-2.04%) | To recent high | -21.3% | To recent low | 4% | Market Cap | $1.229b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |